Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpyrean Regulatory News (EME)

Share Price Information for Empyrean (EME)

Share Price is delayed by 15 minutes
Get Live Data
0.0575    0.00 (0.00%)
Bid:
0.055
Ask:
0.06
Spread: 0.005 (9.091%)
Market Cap: £3.29m
EME Live PriceLast checked at - London Stock Exchange

Intraday Empyrean Share Chart

Operations Update: Riverbend Project

29 May 2013 08:30

RNS Number : 7727F
Empyrean Energy PLC
29 May 2013
 

29 May 2013

 

 

Empyrean Energy PLC

('Empyrean' or the 'Company', (AIM: EME))

 

Operations Update: Riverbend Project, onshore Texas

 

Cartwright-1H well recompletion

 

Empyrean Energy (AIM: EME), the onshore US condensate and gas exploration & production company, is pleased to report that early results from the recompletion of the Cartwright-1H well in the Wilcox interval have been successful and in line with or better than expectations. The well has been turned to sales and is producing gas and oil (condensate). Empyrean holds a 10% Working Interest in the Riverbend Project and Cartwright-1H well.

 

The well produced an average of 745,000 cubic feet of gas per day ("cfgpd") with 40 barrels of oil per day ("bopd") for the first 7 days production post testing and an average of 755,000 cfgpd with 37 bopd for the first 14 days of production post testing.

 

The early oil production is in line with expectations (30-40 bopd) and the early gas production is above expectations (200,000 -250,000 cfgpd).

 

The choke setting is currently 12/64 with approximately 10 barrels of water being produced per day with the hydrocarbons.

Empyrean will make further announcements to update in due course as a greater production profile is achieved and the operator notifies Empyrean of future development planning.

 

Commenting today, Empyrean CEO, Tom Kelly said, "These early results are very encouraging for the initial recompletion goal of achieving economically viable production from the Cartwright-1H well."

 

The information contained in this announcement was completed and reviewed by the Technical Director of Empyrean Energy Plc, Mr Frank Brophy BSc (Hons) who has over 40 years experience as a petroleum geologist.

 

For further information

Empyrean Energy plc 

Tom Kelly

+618 9480 0111

 

Shore Capital

Anita Ghanekar

Edward Mansfield

+44 (0) 207 408 4090

 

Jonathan Charles

Lionsgate Communications

E: jcharles@lionsgatecomms.comM: +44 (0)7791 892509 

www.lionsgatecomms.com 

 

 

Notes to Editors:

 

Empyrean Energy Plc is an AIM-listed (Ticker: EME) condensate and gas exploration and production company focused on the Eagle Ford Shale, Texas, USA. Other assets include a 10% working interest in the Riverbend Project, Texas, just north of the prolific Brookeland Field (Austin Chalk) as well as a 57.2% interest in the Eagle Oil Pool Development Project located in the San Joaquin Basin, southern California.

Empyrean's portfolio includes an interest in over 85 producing wells with scaleable growth potential from further development and exploration upside.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDKLBLXEFLBBF
Date   Source Headline
16th Jan 20207:11 amRNSEmpyrean raises £420,000
24th Dec 20199:03 amRNSInterim Results
24th Dec 20199:00 amRNS£10m Equity Placement Facility secured
22nd Nov 20197:45 amRNSDuyung PSC, Operational Update - Tambak -1
13th Nov 20197:00 amRNSDuyung PSC, Operational Update - Tambak -1
4th Nov 20198:00 amRNSOperational Update - Tambak -1 Well Spud
25th Oct 20197:15 amRNSDuyung PSC, Operational Update
15th Oct 20197:00 amRNSDuyung PSC, Ops Update - Tambak-2 Well reaches TD
4th Oct 20198:00 amRNSDuyung PSC, Ops Update - Tambak 2 Well Spud
26th Sep 20197:00 amRNSEmpyrean raises £365,580 before costs
24th Sep 20197:00 amRNSDuyung PSC, Operational Update
18th Sep 201911:28 amRNSGrant of Options and PDMR Notification
10th Sep 201910:45 amRNSResult of AGM
10th Sep 20198:00 amRNSCompany Presentation
19th Aug 20197:00 amRNSDuyung PSC, Operational Update
16th Aug 201910:30 amRNSNotice of AGM & Posting of Annual Report
9th Aug 20199:55 amRNSFinal Results
9th Jul 20198:00 amRNSExercise of Options
15th May 20197:00 amRNSFurther Exploration Risk Mitigation on China Block
29th Apr 20197:00 amRNSMako Gas Field appraisal & drill programme
17th Apr 20197:00 amRNSFirst Completion of Reduction of Duyung Interest
11th Mar 20197:00 amRNSPlan of Development Approval for Mako Gas Field
11th Feb 20197:00 amRNSReduction of Interest in Duyung for Cash & Shares
21st Jan 20197:25 amRNSIndependent Resource Audit of Mako Gas Field
21st Dec 20188:48 amRNSInterim Results
6th Dec 201812:26 pmRNSHolding(s) in Company
16th Nov 20188:11 amRNSA £1 Million Placement
9th Nov 20187:30 amRNSIndependent Oil in-place Estimates for Block 29/11
4th Oct 20189:46 amRNSDirector/PDMR Shareholding
1st Oct 20188:40 amRNSPetroleum Contract for Block 29/11 signed
5th Sep 201812:20 pmRNSResult of Annual General Meeting
5th Sep 20189:38 amRNSCompany Presentation
5th Sep 20187:00 amRNSThird-party Independent STOIIP Audit, Block 29/11
30th Aug 20187:00 amRNSAlvares 1 Testing and Operations Update
13th Aug 20187:38 amRNSIRS Tax Refund
10th Aug 20187:00 amRNSPosting of Annual Report and Notice of AGM
6th Aug 20187:00 amRNSFinal Results
3rd Aug 20187:46 amRNSOperations Update from Mako Gas Discovery
17th Jul 20187:37 amRNSTax refunds totalling $1.3 million
18th Jun 20187:50 amRNSOil Migration Study Completed - Block 29/11
6th Jun 20187:00 amRNS31% Uplift in Prospective Resources in Block 29/11
23rd May 20187:00 amRNSCommercial gas flows at ~1,200 mcfpd from Dempsey
8th May 20187:00 amRNSCommercial Gas Flows From Dempsey
3rd May 20189:10 amRNSHoldings in Company
16th Apr 20187:25 amRNSDempsey Testing Update
12th Mar 20187:10 amRNSDempsey Testing Update
8th Mar 20187:15 amRNSDempsey Production Testing to Resume
20th Feb 20182:45 pmRNSExercise of Options
30th Jan 201810:45 amRNSGrant of Options and PDMR Notification
17th Jan 20187:00 amRNSProduction & Sales from Dempsey Well Commences

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.